We are international
Donate
TEXT SIZE   


Research
01.28.10

We need more money for research to discover and test new and better drugs and other forms of treatment.

 We have come a long way in the past 20 years. New drugs like thalidomide, lenalidomide, bortezimib, and others have revolutionized the treatment of multiple myeloma – but they don’t prevent progression of myeloma forever.

  • We need Congress to maintain and add to the annual research budget of the National Cancer Institute (and we work with several partners to support this initiative)

  • We need the pharmaceutical and biotechnology industries to develop innovative new agents that are better than what we have today – and bring them to market as fast as they can.

  • We need to understand how we can prevent and limit the risk for myeloma, so that future generations can avoid the problems associated with this disease.

Have a look at What YOU Can Do to help.

To get the details about our advocacy priorities, look at our Statement of Principles.


 related articles
A Patient Advocacy Coalition Led by the International Myeloma Foundation and the MDS Foundation Says Its Cancer Patient Statement of Principles Gains Momentum Going into the ASH Cancer Conference
Advocacy Staff
Advocacy Update - August 17, 2010
Advocacy Update - August 31, 2010
Advocacy Update - February 15, 2010
Advocacy Update - July 15, 2010
Advocacy Update - June 21, 2010
Advocacy Update - June 30, 2010
Advocacy Update - May 31, 2010
Advocacy Update - September 1, 2009
Advocacy Update - September 15, 2009
Advocacy Update - September 30, 2010
Advocacy Update
August 5, 2010
IMF supports legislation to require equitable insurance reimbursement for oral cancer drugs
Issues of importance to patients are getting lost in partisan battles in Congress. Get involved!
Myeloma Advocacy Update - January 31, 2010
Myeloma Advocacy Update - March 30, 2010
New! Survey of your experience in obtaining access to the cancer medications recommended by your physician.
President Unveils Health Reform Proposal
Statement on the passing of Senator Kennedy
The Importance of Voting on November 2nd
The International Myeloma Foundation, Marking 20 Years of Serving the Myeloma Community, Applauds, Members of the International Myeloma Working Group for Their Body of Work Being Presented at the ASH Hematology Conference
The Power of Advocacy
Virginia Support Group Leader Takes on Capitol Hill